Postoperative seizure in high grade glioma patients treated with BCNU wafers. A mono-institutional experience

Journal of Neuro-Oncology

Volumn 105, Issue 2, 2011, Pages 275-280

  Della Puppa, Alessandro ^a   Denaro, Luca ^a   Rossetto, Marta ^a   Ciccarino, Pietro ^a   Manara, Renzo ^a   Lombardi, Giuseppe ^b   Del Moro, Giulia ^a   Rotilio, Antonino ^a   D'Avella, Domenico ^a   Scienza, Renato ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

BCNU wafers; Carmustine wafers; High grade gliomas; Seizure

Indexed keywords

CARBAMAZEPINE; CARMUSTINE; ETIRACETAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; BRAIN EDEMA; BRAIN SURGERY; CANCER GRADING; CANCER LOCALIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG IMPLANTATION; FEMALE; FOLLOW UP; GLIOMA; HUMAN; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; RISK FACTOR; SEIZURE;

EID: 84942303267     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0577-6     Document Type: Article

References (20)

1. Sabel M, Giese A (2008) Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience. Curr Med Res Opin. doi: 10.1185/03007990802508180
2. MJ Glantz BF Cole PA Forsyth, et al. 2000 Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the quality standards subcommittee of the American academy of neurology Neurology 54 1886 1893 10822423 1:STN:280:DC%2BD3c3osVWhsA%3D%3D (Pubitemid 30327107)
3. MS van Breemen EB Wilms CJ Vecht 2007 Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management Lancet Neurol 6 421 430 17434097 10.1016/S1474-4422(07)70103-5 (Pubitemid 46551867)
4. H Brem S Piantadosi PC Burger M Walker R Selker NA Vick K Black M Sisti S Brem G Mohr P Muller R Morawetz S Clifford Schold 1995 Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain tumor treatment group Lancet 345 1008 1012 7723496 10.1016/S0140-6736(95)90755-6 1:STN:280:DyaK2M3ktVansw%3D%3D
5. M Westphal DC Hilt E Bortey P Delavault R Olivares PC Warnke IR Whittle J Jääskeläinen Z Ram 2003 A Phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro-Oncology 5 79 88 12672279 1:CAS:528: DC%2BD3sXjtVKltL4%3D (Pubitemid 36422560)
6. Asher AL (2007) Prospective analysis of temozolomide as adjuvant to Gliadel and radiation in newly diagnosed malignant glioma. Abstract presented at the Annual Meeting of the American Association of Neurological Surgeons, Washington 2007
7. FJ Attenello D Mukherjee G Datoo MJ McGirt E Bohan JD Weingart A Olivi A Quinones-Hinojosa H Brem 2008 Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience Ann Surg Oncol 15 2887 2893 18636295 10.1245/s10434-008-0048-2
8. Dal Pan G, Butler L, Schactman M (1997) Preliminary analysis of the GLIADEL treatment protocol. Abstract presented at the ASCO Annual Meeting, Atlanta 1997
9. BJ Darakchiev RE Albright JC Breneman RE Warnick 2008 Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme J Neurosurg 108 236 242 18240917 10.3171/JNS/2008/108/2/0236 (Pubitemid 351213285)
10. Giese A, Bock H.C., Kantelhardt S.R., Rohde V. (2010): Risk Management in the Treatment of Malignant Gliomas with BCNU Wafer Implants. Cent Eur Neurosurg. doi: 10.1055/s-0029-1242775
11. D Gonza'lez Vidal 2006 The safety of Gliadel implants during the indication period in recurrent surgery in the treatment of glioblastoma multiforme [abstract] NeurocirugIa 17 77 78
12. S Gururangan L Cokgor JN Rich S Edwards ML Affronti JA Quinn JE Herndon II JM Provenzale RE McLendon S Tourt-Uhlig JH Sampson V Stafford-Fox S Zaknoen M Early AH Friedman HS Friedman 2001 Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas Neuro-Oncology 3 246 250 11584894 1:CAS:528:DC%2BD38Xks1Olsrs%3D (Pubitemid 33674145)
13. LR Kleinberg J Weingart P Burger K Carson SA Grossman K Li A Olivi MD Wharam H Brem 2004 Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management Cancer Invest 22 1 9 15069758 10.1081/CNV-120027575
14. MJ McGirt KD Than JD Weingart KL Chaichana FJ Attenello A Olivi J Laterra LR Kleinberg SA Grossman H Brem A Quiñones-Hinojosa 2009 Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme J Neurosurg Mar 110 583 588 10.3171/2008.5.17557 1:CAS:528:DC%2BD1MXjvVyns7g%3D
15. PC McGovern E Lautenbach PJ Brennan RA Lustig NO Fishman 2003 Risk factors for post-craniotomy surgical site infection after 1, 3-bis(2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement Clin Infect Dis 36 759 765 12627360 10.1086/368082 1:CAS:528:DC%2BD3sXjtVKqtbc%3D (Pubitemid 36337980)
16. E Pan SB Mitchell JS Tsai 2008 A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients J Neurooncol 88 353 357 18389176 10.1007/s11060-008-9576-7
17. BR Subach TF Witham D Kondziolka LD Lunsford M Bozik D Schiff 1999 Morbidity and survival after 1, 3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case matched cohort series Neurosurgery 45 17 22 10414561 10.1097/00006123-199907000-00004 1:STN:280:DyaK1MzktFGisw%3D%3D (Pubitemid 29318869)
18. Tait MJ, Critchley GR (2006) Experience of revision craniotomy for debulking of high grade gliomas in 27 patients in a single UK centre, with and without insertion of carmustine wafers. Meeting of the Society of British Neurosurgeons, Preston
19. J Weingart SA Grossman KA Carson JD Fisher SM Delaney ML Rosenblum A Olivi K Judy SB Tatter ME Dolan 2007 Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial J Clin Oncol 25 399 404 17264335 10.1200/JCO.2006.06.6290 1:CAS:528:DC%2BD2sXisFykur0%3D (Pubitemid 350002988)
20. A Della Puppa M Rossetto P Ciccarino G Del Moro A Rotilio R Manara MP Gardiman L Denaro D d'Avella R Scienza 2010 The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series Acta Neurochir (Wien) 152 1923 1931 10.1007/s00701-010-0759-6 10.1007/s00701-010-0759-6